TY - JOUR
T1 - Discovery and Characterization of Bicereucin, an Unusual d -Amino Acid-Containing Mixed Two-Component Lantibiotic
AU - Huo, Liujie
AU - Van Der Donk, Wilfred A.
N1 - Publisher Copyright:
© 2016 American Chemical Society.
PY - 2016/4/27
Y1 - 2016/4/27
N2 - Lantibiotics are a group of ribosomally synthesized and post-translationally modified peptides (RiPPs) exhibiting antimicrobial activity. They are characterized by the presence of the thioether-containing bisamino acids lanthionine and methyllanthionine. Here, we report a two-component lantibiotic from Bacillus cereus SJ1 with unusual structural features that we named bicereucin. Unlike all previous two-component lantibiotics, only one of the two peptides of bicereucin contains a lanthionine. The second peptide lacks any cysteines but contains several d-amino acids. These are installed by the dehydrogenase BsjJB, the activity of which was successfully reconstituted in vitro. The proteolytic removal of the leader peptide was also performed in vitro. Bicereucin displayed synergistic antimicrobial activities against Gram-positive strains including methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci as well as hemolytic activity. To illustrate the utility of the enzymes, an analog of the d-amino acid containing opioid dermorphin was successfully produced in E. coli by employing the dehydratase BsjM and the dehydrogenase NpnJA.
AB - Lantibiotics are a group of ribosomally synthesized and post-translationally modified peptides (RiPPs) exhibiting antimicrobial activity. They are characterized by the presence of the thioether-containing bisamino acids lanthionine and methyllanthionine. Here, we report a two-component lantibiotic from Bacillus cereus SJ1 with unusual structural features that we named bicereucin. Unlike all previous two-component lantibiotics, only one of the two peptides of bicereucin contains a lanthionine. The second peptide lacks any cysteines but contains several d-amino acids. These are installed by the dehydrogenase BsjJB, the activity of which was successfully reconstituted in vitro. The proteolytic removal of the leader peptide was also performed in vitro. Bicereucin displayed synergistic antimicrobial activities against Gram-positive strains including methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci as well as hemolytic activity. To illustrate the utility of the enzymes, an analog of the d-amino acid containing opioid dermorphin was successfully produced in E. coli by employing the dehydratase BsjM and the dehydrogenase NpnJA.
UR - http://www.scopus.com/inward/record.url?scp=84966290813&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84966290813&partnerID=8YFLogxK
U2 - 10.1021/jacs.6b02513
DO - 10.1021/jacs.6b02513
M3 - Article
C2 - 27074593
AN - SCOPUS:84966290813
SN - 0002-7863
VL - 138
SP - 5254
EP - 5257
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 16
ER -